Duration of adjuvant therapy for patients with gastrointestinal stromal tumors: Where is goldilocks when we need her?

Charles Blanke, Ronald P. DeMatteo

Research output: Contribution to journalShort survey

3 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)721-722
Number of pages2
JournalJAMA oncology
Volume2
Issue number6
DOIs
StatePublished - Jun 1 2016

Fingerprint

Medication Therapy Management
Molecular Targeted Therapy
Gastrointestinal Stromal Tumors
Therapeutics
Imatinib Mesylate

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Duration of adjuvant therapy for patients with gastrointestinal stromal tumors : Where is goldilocks when we need her? / Blanke, Charles; DeMatteo, Ronald P.

In: JAMA oncology, Vol. 2, No. 6, 01.06.2016, p. 721-722.

Research output: Contribution to journalShort survey

@article{9c6f35eb54ce40c4b5d2a2fb20bbecfd,
title = "Duration of adjuvant therapy for patients with gastrointestinal stromal tumors: Where is goldilocks when we need her?",
author = "Charles Blanke and DeMatteo, {Ronald P.}",
year = "2016",
month = "6",
day = "1",
doi = "10.1001/jamaoncol.2016.0094",
language = "English (US)",
volume = "2",
pages = "721--722",
journal = "JAMA oncology",
issn = "2374-2437",
publisher = "American Medical Association",
number = "6",

}

TY - JOUR

T1 - Duration of adjuvant therapy for patients with gastrointestinal stromal tumors

T2 - Where is goldilocks when we need her?

AU - Blanke, Charles

AU - DeMatteo, Ronald P.

PY - 2016/6/1

Y1 - 2016/6/1

UR - http://www.scopus.com/inward/record.url?scp=85010280687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010280687&partnerID=8YFLogxK

U2 - 10.1001/jamaoncol.2016.0094

DO - 10.1001/jamaoncol.2016.0094

M3 - Short survey

C2 - 27031092

AN - SCOPUS:85010280687

VL - 2

SP - 721

EP - 722

JO - JAMA oncology

JF - JAMA oncology

SN - 2374-2437

IS - 6

ER -